These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11073809)

  • 1. Astrocytic alterations in interleukin-6/Soluble interleukin-6 receptor alpha double-transgenic mice.
    Brunello AG; Weissenberger J; Kappeler A; Vallan C; Peters M; Rose-John S; Weis J
    Am J Pathol; 2000 Nov; 157(5):1485-93. PubMed ID: 11073809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of IL-6 trans-signaling in vascular leakage: implications for ovarian hyperstimulation syndrome in a murine model.
    Wei LH; Chou CH; Chen MW; Rose-John S; Kuo ML; Chen SU; Yang YS
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E472-84. PubMed ID: 23348396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IL-6-soluble IL-6Ralpha autocrine loop of endothelial activation as an intermediate between acute and chronic inflammation: an experimental model involving thrombin.
    Marin V; Montero-Julian FA; Grès S; Boulay V; Bongrand P; Farnarier C; Kaplanski G
    J Immunol; 2001 Sep; 167(6):3435-42. PubMed ID: 11544336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose glucocorticoids increase serum levels of soluble IL-6 receptor alpha and its ratio to soluble gp130: an additional mechanism for early increased bone resorption.
    Dovio A; Perazzolo L; Saba L; Termine A; Capobianco M; Bertolotto A; Angeli A
    Eur J Endocrinol; 2006 May; 154(5):745-51. PubMed ID: 16645023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble IL-6 receptor induces calcium flux and selectively modulates chemokine expression in human dermal fibroblasts.
    Spörri B; Müller KM; Wiesmann U; Bickel M
    Int Immunol; 1999 Jul; 11(7):1053-8. PubMed ID: 10383937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6 controls the innate immune response against Listeria monocytogenes via classical IL-6 signaling.
    Hoge J; Yan I; Jänner N; Schumacher V; Chalaris A; Steinmetz OM; Engel DR; Scheller J; Rose-John S; Mittrücker HW
    J Immunol; 2013 Jan; 190(2):703-11. PubMed ID: 23241882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of IL-6 and its soluble receptor on proteoglycan synthesis and NO release by human articular chondrocytes: comparison with IL-1. Modulation by dexamethasone.
    Guerne PA; Desgeorges A; Jaspar JM; Relic B; Peter R; Hoffmeyer P; Dayer JM
    Matrix Biol; 1999 Jun; 18(3):253-60. PubMed ID: 10429944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic mice.
    Schirmacher P; Peters M; Ciliberto G; Blessing M; Lotz J; Meyer zum Büschenfelde KH; Rose-John S
    Am J Pathol; 1998 Aug; 153(2):639-48. PubMed ID: 9708822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloma cells release soluble interleukin-6Ralpha in relation to disease progression by two distinct mechanisms: alternative splicing and proteolytic cleavage.
    Thabard W; Barillé S; Collette M; Harousseau JL; Rapp MJ; Bataille R; Amiot M
    Clin Cancer Res; 1999 Oct; 5(10):2693-7. PubMed ID: 10537331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An epithelial gene signature of trans-IL-6 signaling defines a subgroup of type 2-low asthma.
    El-Husseini ZW; Khalenkow D; Lan A; van der Molen T; Brightling C; Papi A; Rabe KF; Siddiqui S; Singh D; Kraft M; Beghe B; van den Berge M; van Gosliga D; Nawijn MC; Rose-John S; Koppelman GH; Gosens R
    Respir Res; 2023 Dec; 24(1):308. PubMed ID: 38062491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of IL-6 trans-signaling on the pro-remodeling phenotype of airway smooth muscle.
    Ammit AJ; Moir LM; Oliver BG; Hughes JM; Alkhouri H; Ge Q; Burgess JK; Black JL; Roth M
    Am J Physiol Lung Cell Mol Physiol; 2007 Jan; 292(1):L199-206. PubMed ID: 16936245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6 trans-signaling in formation and progression of malignant ascites in ovarian cancer.
    Lo CW; Chen MW; Hsiao M; Wang S; Chen CA; Hsiao SM; Chang JS; Lai TC; Rose-John S; Kuo ML; Wei LH
    Cancer Res; 2011 Jan; 71(2):424-34. PubMed ID: 21123455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of IL-6 and soluble IL-6 receptor on the expression of cartilage matrix proteins in human chondrocytes.
    Namba A; Aida Y; Suzuki N; Watanabe Y; Kawato T; Motohashi M; Maeno M; Matsumura H; Matsumoto M
    Connect Tissue Res; 2007; 48(5):263-70. PubMed ID: 17882702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of CD8(+) T cells lacking the IL-6 receptor α chain in patients with coronary artery diseases (CAD).
    Hwang Y; Yu HT; Kim DH; Jang J; Kim HY; Kang I; Kim HC; Park S; Lee WW
    Atherosclerosis; 2016 Jun; 249():44-51. PubMed ID: 27062409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOCS3 limits TNF and endotoxin-induced endothelial dysfunction by blocking a required autocrine interleukin-6 signal in human endothelial cells.
    Martino N; Bossardi Ramos R; Chuy D; Tomaszek L; Adam AP
    Am J Physiol Cell Physiol; 2022 Aug; 323(2):C556-C569. PubMed ID: 35816643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An aminopeptidase, ARTS-1, is required for interleukin-6 receptor shedding.
    Cui X; Rouhani FN; Hawari F; Levine SJ
    J Biol Chem; 2003 Aug; 278(31):28677-85. PubMed ID: 12748171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression.
    März P; Heese K; Dimitriades-Schmutz B; Rose-John S; Otten U
    Glia; 1999 May; 26(3):191-200. PubMed ID: 10340760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble IL-6 receptor leads to a paracrine modulation of the IL-6-induced hepatic acute phase response in double transgenic mice.
    Peters M; Odenthal M; Schirmacher P; Blessing M; Fattori E; Ciliberto G; Meyer zum Buschenfelde KH; Rose-John S
    J Immunol; 1997 Aug; 159(3):1474-81. PubMed ID: 9233646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression.
    Oh JW; Van Wagoner NJ; Rose-John S; Benveniste EN
    J Immunol; 1998 Nov; 161(9):4992-9. PubMed ID: 9794436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow stromal cells reduce ischemia-induced astrocytic activation in vitro.
    Gao Q; Li Y; Shen L; Zhang J; Zheng X; Qu R; Liu Z; Chopp M
    Neuroscience; 2008 Mar; 152(3):646-55. PubMed ID: 18313231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.